Search

everythinglearnresearchcommunity

for

Search:↓

Certain plasma proteins and genes are linked to obstructive sleep apnea, suggesting potential new treatments.

Calcipotriol's effectiveness for treating alopecia areata is unclear and needs more research.

Alopecia areata is linked to immune system differences, with specific biomarkers like CXCL9 and CXCL10 being key for diagnosis and potential treatment targets.

Histone modification is key in treating chronic inflammatory skin diseases.

The skin microbiome helps heal wounds and can be targeted to improve healing.

MSC-derived exosomes can help treat COVID-19, hair loss, skin aging, and arthritis.

TNC+ fibroblasts play a key role in skin inflammation by interacting with T cells.

Targeting NETs may help reduce fibrosis in Crohn's disease.

Alopecia areata is an autoimmune condition causing hair loss, linked to genetic factors and immune system issues, with no cure yet.

Live imaging helps us understand skin immune responses and develop treatments.

Alopecia areata may be treated by using EGCG to balance immune cells and reduce inflammation.

Hidradenitis Suppurativa is likely an autoinflammatory disease, and better understanding its causes could improve treatments.

Glycemic control medications for Type 2 diabetes can affect skin conditions like psoriasis.

Ginseng and its compounds may help hair growth and prevent hair loss, but more human trials are needed to confirm this.

Vitamins A, B3, C, D, and E can improve skin health and immunity.

HO-1 helps skin health and healing but can worsen melanoma; it's a potential treatment target for skin diseases.

Hydrogel microcapsules help create cells that boost hair growth.

Skin reactions are a common reason for emergency visits due to drug allergies, with some severe cases needing intensive care.

Gut microbiota changes might play a role in alopecia areata, and microbiome-targeted treatments show promise.

Alopecia areata is a hair loss condition caused by immune factors and can be treated with JAK inhibitors.

Tofacitinib may be safe for COVID-19 patients with alopecia without worsening symptoms, based on two cases.

Transforming skin disease treatment requires new strategies, better drug models, and patient-focused research.

People with alopecia areata may have a higher risk of blood clots.

Tofacitinib temporarily regrew hair in a man with alopecia, but its effects didn't last.

People with alopecia areata often have higher rates of allergies and autoimmune diseases.

New treatments for hair loss are showing promise due to better understanding of genetics and the immune system.

Targeting immune tolerance issues in Alopecia Areata could restore hair growth and maintain remission.

Allergies and atopic conditions may increase the risk of developing alopecia areata.

Environmental factors like diet and vitamin levels, especially Vitamin D, can affect autoimmune diseases differently, with lifestyle changes potentially improving outcomes.

New treatments targeting T-cell pathways are needed for better alopecia areata management.